Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

KO · Q3 2025 Earnings

Coca-Cola Company (The)

Reported October 21, 2025

30-second summary

30-second take: Coca-Cola delivered 6% organic revenue growth on +1% unit case volume and +6% price/mix, with currency-neutral operating income up 15% and comparable operating margin at 31.9%. Management raised FY2025 free cash flow guidance to at least $9.8B (from ~$9.5B) and improved the Q4 EPS FX headwind to 4–5% (from 5–6%), while reaffirming the FY organic revenue (5–6%) and currency-neutral EPS (~8%) frameworks. The notable subtext: volume's recovery was framed as execution-driven, not demand-driven, and management telegraphed a 2026 organizational restructuring — a more cautious posture than the headline numbers suggest.

Headline numbers

EPS

Q3 FY2025

$0.82

Revenue

Q3 FY2025

$12.46B

+5.0% YoY

Gross margin

Q3 FY2025

61.5%

Operating margin

Q3 FY2025

32.0%

Key financials

Q3 FY2025

Metric	Q3 FY2025	YoY	Q2 FY2025	QoQ
Revenue	$12.46B	+5.0%	$12.54B	-0.6%
EPS	$0.82	—	$0.87	-5.7%
Gross margin	61.5%	—	62.4%	-90bps
Operating margin	32.0%	—	34.1%	-210bps

Guidance

Coca-Cola raises FY2025 free cash flow guidance to at least $9.8B while improving Q4 currency headwind outlook; full-year organic growth and EPS guidance reaffirmed.

Guidance is issued for both next quarter and the full year. Both may appear below.

New guidance

Metric	Period	Guide	YoY
Comparable net revenues currency impact	Q4 FY 2025	slight currency tailwind	—

Changes to prior guidance

Metric	Period	Prior guide	New guide	Δ	Result
Free cash flow (excluding fairlife contingent consideration payment)	FY 2025	approximately $9.5 billion	at least $9.8 billion	+$0.3 billion	Raised
Underlying effective tax rate	FY 2025	20.8%	20.7%	-0.1 percentage points	Lowered
Comparable net revenues currency headwind	Q4 FY 2025	approximate 1%	Withdrawn — no replacement	—	Withdrawn
Comparable EPS currency headwind	Q4 FY 2025	5% to 6%	4% to 5%	-1 to -2 percentage points (headwind reduced)	Raised

Reaffirmed unchanged this quarter: Organic revenue growth (5% to 6%), Comparable currency neutral EPS growth (approximately 8%), Comparable EPS (non-GAAP) growth (approximately 3% versus $2.88 in 2024)

Segment performance

Q3 FY2025

Segment	Q3 FY2025	YoY
Bottling Investments	$1.346B	+2.0%

Platform metrics

Q3 FY2025

Segment	Q3 FY2025
Unit Case Volume Growth	1%
Organic Revenue Growth (Non-GAAP)	6%
Price/Mix Growth	6%
Concentrate Sales Growth	0%
Coca-Cola Zero Sugar Volume Growth	14%
Value Share - Total NARTD Beverages	Gained share

Profitability

Q3 FY2025

Segment	Q3 FY2025
Comparable Operating Margin (Non-GAAP)	31.9%
Comparable Currency Neutral Operating Income Growth (Non-GAAP)	15%

Other KPIs

Q3 FY2025

Segment	Q3 FY2025	YoY
Europe, Middle East & Africa	$2.996B	+10.0%
Latin America	$1.573B	-4.0%
North America	$5.253B	+4.0%
Asia Pacific	$1.506B	+11.0%

Management tone

Q1 FY2025 confidence in algorithm → Q2 "all-weather strategy" defensiveness → Q3 transparent acknowledgment that recovery is execution-driven and restructuring is coming.

Volume reframed as execution win, not demand recovery. Last quarter management flagged concentrate running behind cases and a soft Q3 setup; the bounce to +1% unit case volume could easily have been spun as macro improvement. Instead, CEO James Quincey explicitly disowned that framing: "I don't think the environment changed markedly in September from July and August. We just got more focused on drilling down into what needed to be done." This is the second consecutive quarter where management is more cautious than the print warrants — a meaningful tell about how they read the underlying consumer.

Pricing strategy is shifting from price-led to balanced. Q2 leaned into "intense inflationary pricing fading from 5 points to 1 point" as a structural fact to absorb. This quarter the framing pivots forward: "we anticipate pricing to normalize and we lean into both affordability and premiumization depending on what the market demands" with "volume as a key priority." Two quarters ago volume was an output of the algorithm; now it is explicitly the priority lever. That is a real strategic shift for a company whose revenue line has been carried by price/mix for two years.

Restructuring is now telegraphed, not hinted. Q2's tone implied steady-state optimization; Q3 makes it explicit: "we will do some restructuring of the organization in 2026" and the striking "The future belongs to the discontented." Combined with re-franchising being characterized as having "a clear line of sight to complete," management is positioning 2026 as a transformation year — productivity programs shifting from episodic to systematic. The cost of that transformation has not been quantified.

Asia-Pacific pricing was self-corrected. Quincey walked back the prior-quarter narrative: APAC pricing "shot up… is the inverse of what normally happens" — explaining the optical strength as a portfolio-mix-out effect from emerging market weakness (India monsoon, China pressure, ASEAN softness), not real pricing power. This is the kind of voluntary correction that should raise credibility but also lowers the quality of the APAC line.

FX flipped from headwind to tailwind — and management did not lean in. Q4 net revenue FX moved from ~1% headwind to "slight tailwind"; EPS FX headwind narrowed by 100–200bps. Yet the FY EPS guide was reaffirmed at ~3%, not raised. Either operational performance has softened to absorb the FX benefit, or management is building a cushion. Neither interpretation is bullish.

Recurring themes management leaned on this quarter:

Consumer bifurcation (top vs. bottom income segments under sustained pressure)Volume growth elusive despite execution improvements; reliance on pricing and mixLocalization and regional adaptation over global-one playbookRe-franchising completion unlocking margin and focus on core brand/innovationProductivity and cost efficiency as funding mechanism for growth investmentFairlife/Core Power capacity constraints easing in H2 2026; protein category structural tailwind

Risks management surfaced:

Tougher volume comparisons in Q4 key markets cycling steep prior-year compsMexico sugar tax (significant increase effective January 1, 2026) creating near-term headwindSofter consumer spending in Asia-Pacific (India monsoon, China economic pressure, ASEAN weakness)Geopolitical uncertainty and trade dynamics creating volatile macro backdropGLP-1 shift reducing full-sugar soft drink consumption (though offset by diet/hydration/protein gains)Local and regional competitor intensity rising with pendulum swing toward regionality

Answers to last quarter's watch list

Q3 unit case volume vs. concentrate — Unit cases returned to +1% growth from -1% in Q2; concentrate sales were 0%, so the gap closed in the direction management flagged (concentrate running behind cases). Importantly, management framed the volume bounce as execution-driven, not demand-driven.

Resolved positively

Price/mix decomposition — Price/mix held at +6 points in Q3, matching Q2, but management explicitly signaled pricing will "normalize" and that volume is now the priority — telegraphing that the +6 points is unlikely to persist into 2026.

Continue monitoring

Latin America trajectory — LatAm came in at -4% YoY, identical to Q2. No sequential improvement, and management's commentary highlighted the Mexico sugar tax (effective January 1, 2026) as an additional near-term headwind.

Resolved negatively

Fairlife capacity — Management indicated Core Power/fairlife capacity constraints ease in H2 2026, consistent with the New York facility ramp. No quantified Q3 acceleration was disclosed.

Continue monitoring

Back-half margin — Q3 comparable operating margin of 31.9% is well below Q2's 34.7%, confirming the pulled-forward margin profile that management flagged last quarter. The FY comparable currency-neutral EPS growth guide of ~8% was reaffirmed, so the math still works, but Q4 margin will need to support the full-year framework with no remaining cushion.

Continue monitoring

ASEAN recovery — Management called out ASEAN as one of the regions still under pressure ("ASEAN weakness" listed among Asia softness factors). No quantified improvement disclosed.

Resolved negatively

What to watch into next quarter

Q4 comparable operating margin vs. prior-year 30.0% — with the back-half-weighted framing gone and Q3 at 31.9%, Q4 needs to hold ~30% or better to deliver the reaffirmed FY ~8% currency-neutral EPS growth. Compression below that level would expose the silent removal of the margin-cadence guidance.

Mexico sugar tax impact on LatAm volume in Q1 2026 — significant increase effective January 1, 2026 on a region already running -4% YoY for two consecutive quarters. Watch for first quantified guidance when 2026 commentary begins.

2026 restructuring charge size and EPS impact — management telegraphed organizational restructuring in 2026 but did not quantify cost or savings. First disclosure likely at Q4 print or early 2026.

Q4 unit case volume sustaining ≥+1% — Q3's return to growth was framed as execution, not demand. A relapse to flat or negative in Q4 against tougher comps would validate management's cautious posture and put the FY 5–6% organic guide's volume contribution at risk.

Price/mix decomposition in Q4 — watch for whether the +6 points compresses materially as management's "normalize" language suggests. A sub-5 point print would signal the pricing engine is fading faster than the volume engine is recovering.

FX tailwind flow-through to FY2026 outlook — Q4 net revenue FX flipped to "slight tailwind." If spot rates hold, 2026 should see a real FX benefit; whether management lets it flow through to the initial 2026 guide or absorbs it as cushion will be telling.

Sources

Coca-Cola Q3 FY2025 Earnings Release, SEC filing — https://www.sec.gov/Archives/edgar/data/21344/000162828025045577/a2025q3earningsreleaseex-9.htm
Coca-Cola Q3 FY2025 Earnings Conference Call prepared remarks, October 21, 2025

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.